New York, Jan 9, 2026, 11:43 EST — Regular session
- Rocket Lab shares were up about 4.6% in late morning trading after a volatile week.
- SEC filings showed the CFO and COO sold shares under preset Rule 10b5-1 trading plans.
- Next focus: the company’s next earnings update and any timetable changes for Neutron.
Rocket Lab Corp shares rose 4.6% to $86.87 in late morning trading on Friday, bouncing after a dip a day earlier as investors weighed heavy insider selling disclosed in regulatory filings. (MarketBeat)
The moves matter because Rocket Lab’s rally into year-end has made the stock sensitive to supply — and headlines — when top executives sell. Shares had fallen 1.2% on Thursday to $83.08, after touching $82.26, MarketBeat data showed.
A Form 4 filing showed Chief Financial Officer Adam C. Spice sold 1,365,665 shares on Jan. 5 at weighted-average prices between $72.149 and $78.0435, transactions that add up to about $103.1 million. The filing also showed Spice exercised options to buy 731,330 shares at $1.09, and marked the sales as part of a Rule 10b5-1 plan — a preset instruction that allows insiders to trade automatically. (SEC)
A separate Form 4 showed Chief Operating Officer Frank Klein sold 100,000 shares on Jan. 2 at weighted-average prices ranging from $67.6104 to $75.8002, for about $7.3 million. That sale also flagged a Rule 10b5-1 plan adopted on Sept. 19, the filing showed. (SEC)
Rocket Lab’s stock has surged since December after it won a contract worth up to $805 million from the U.S. Space Development Agency, pushing the company deeper into U.S. national-security work. “We are very encouraged by this contract decision,” Cantor Fitzgerald analyst Andres Sheppard wrote in a Dec. 19 note. (Morningstar)
Needham raised its price target on Rocket Lab to $90 from $63 after the SDA award, pointing to the company’s growing defense footprint, Investors.com reported. The firm has also talked up 2026 expansion plans and a first flight for its Neutron rocket, a larger launcher aimed at a broader market than Electron.
But the stock’s speed cuts both ways. Rocket Lab has a high beta — a measure of how sharply a stock tends to swing versus the broader market — and it remains unprofitable, leaving little room for delays on Neutron or stumbles delivering on large government programs. (Finviz)
Next up is the company’s next quarterly report: market calendars peg Rocket Lab’s next earnings date at Feb. 26. Traders will be listening for any changes to the Neutron schedule, margins, and how fast contract backlog turns into revenue.
